U.S. Software Stock News

NasdaqCM:HOVR
NasdaqCM:HOVRAerospace & Defense

Does New Horizon Aircraft’s (HOVR) Discounted Equity Raise Recast Its Funding Strength or Dilution Risk?

In May 2026, New Horizon Aircraft Ltd. completed a registered direct follow-on equity offering of US$19.90 million, issuing 9,254,889 Class A ordinary shares at US$2.15 each, reflecting a US$0.1505 per-share discount. This capital raise meaningfully expands the company’s funding pool, potentially influencing how investors assess its ability to finance future aircraft development and commercialization efforts. We’ll now examine how this registered direct offering and the added capital reshape...
NYSE:STAG
NYSE:STAGIndustrial REITs

Assessing STAG Industrial (STAG) Valuation After Recent Flat Share Performance And Leasing Momentum

STAG Industrial stock: context for recent performance STAG Industrial (STAG) has drawn investor attention after recent share price moves, with the stock roughly flat over the past week, down around 2% in the past month, and about 3% lower over the past 3 months. See our latest analysis for STAG Industrial. Looking past the recent softness, the stock’s year to date share price return of 3.33% and 1 year total shareholder return of 16.30% suggest longer term holders have seen a steadier payoff...
NYSE:FR
NYSE:FRIndustrial REITs

A Look At First Industrial Realty Trust (FR) Valuation As Shares Trade Near Analyst Fair Value Estimates

Why First Industrial Realty Trust is on investors’ radar today First Industrial Realty Trust (FR) is drawing attention after recent trading data showed a mixed return picture, with the stock roughly flat over the past month but higher over the past 3 months and year to date. See our latest analysis for First Industrial Realty Trust. With the share price at US$63.28 and a 7 day share price return of 4.0%, recent moves suggest building momentum on top of a year to date share price return of...
NYSE:VFC
NYSE:VFCLuxury

V F Turnaround Story Gains Traction As Sales And Margins Improve

V.F (NYSE:VFC) has returned to sales growth after three years of declines. The company reports meaningful operating margin expansion and lower net debt. Vans is showing early signs of recovery in the Americas direct to consumer channel. Management has reinstated annual guidance alongside continued strength at The North Face and Timberland. For investors tracking NYSE:VFC, the latest update marks a clear shift in the story. After several tough years, the company now reports sales growth...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

Dividend Hike Could Be A Game Changer For International General Insurance Holdings (IGIC)

International General Insurance Holdings Ltd. previously announced that its Board approved a 50% increase in the quarterly ordinary common share dividend to US$0.075 per share, with the first payment at this higher rate made on June 11, 2026, to shareholders of record as of May 28, 2026. This sizeable step-up in regular cash returns highlights the Board’s confidence in the company’s capital position and its ongoing capacity to return cash to shareholders through a higher recurring payout. We...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Webull (BULL) Revenue Growth Contrasts With Renewed Q1 Loss And Tests Bullish Narratives

Webull (BULL) kicked off Q1 2026 with total revenue of about US$159.9 million and basic EPS that slipped into a loss of about US$0.04, while the trailing twelve month figures show revenue of roughly US$606.9 million and a basic EPS loss of about US$1.01. Over the past year, the company has seen quarterly revenue move from about US$117.4 million in Q1 2025 to US$159.9 million in Q1 2026, with basic EPS swinging between profits and losses across those periods. For investors, the latest numbers...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative

In May 2026, Indivior Pharmaceuticals reported two real-world evidence studies showing that adherence to its monthly injectable buprenorphine, SUBLOCADE, was associated with substantially lower relapse risk, fewer serious infections, and reduced healthcare utilization in people with opioid use disorder. Because these analyses linked SUBLOCADE use to both clinical and healthcare resource benefits, they may strengthen the drug’s appeal to clinicians, payers, and treatment programs seeking more...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

Akso Health Group (AHG) Valuation Check After Auditor Change To CHI LLTC

Akso Health Group (NasdaqCM:AHG) has changed its independent registered public accounting firm, with the audit committee dismissing Onestop Assurance PAC and appointing CHI-LLTC, a governance-focused move that can reshape how investors view its reporting. See our latest analysis for Akso Health Group. The auditor change comes as the stock trades at US$1.53, with the share price down 22.73% over the past month but up 13.50% over 90 days. The 3 year total shareholder return is very large, which...
NYSE:FLO
NYSE:FLOFood

Has Flowers Foods (FLO) Fallen Too Far After Sharp One-Year Share Price Slide?

If you are wondering whether Flowers Foods at around US$7.94 is a bargain or a value trap, the answer starts with understanding how its current price stacks up against a few simple valuation checks. The stock has been volatile, with a rise of 10.6% over the past week but declines of 9.3% over the past month, 26.4% year to date, and 47.7% over the last year, which can change how investors think about both risk and opportunity. Recent coverage has focused on how this long slide in the share...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Why Nextpower (NXT) Is Down 9.6% After Raising Guidance And Buying Zigor’s Power Business

Earlier in May, Nextpower Inc. reported fiscal 2026 results showing full-year sales of US$3.56 billion and net income of US$585.88 million, while also raising its fiscal 2027 revenue guidance to US$3.8 billion–US$4.1 billion and outlining higher GAAP earnings expectations. Alongside these results, Nextpower announced an asset purchase agreement for Zigor Corp.’s power conversion business and Apex Power, marking a push into battery energy storage and data center markets that broadens its...
NYSE:DGX
NYSE:DGXHealthcare

Is Quest’s Strong Q1 Beat and Raised 2026 Outlook Altering The Investment Case For Quest Diagnostics (DGX)?

Earlier this month, Quest Diagnostics reported first-quarter 2026 adjusted earnings per share of US$2.50 and revenue of US$2.90 billion, both ahead of analyst estimates, supported by a 10.9% increase in testing volumes and an updated full-year 2026 outlook with higher revenue and earnings guidance. The Board also reaffirmed capital returns by declaring a quarterly cash dividend of US$0.86 per share, payable on July 22, 2026, to shareholders of record on July 8, 2026, underscoring...
NYSE:OGS
NYSE:OGSGas Utilities

Is It Too Late To Consider ONE Gas (OGS) After Recent Share Price Strength?

Wondering whether ONE Gas at around US$82.50 is offering good value right now, or whether the recent price leaves limited upside. The stock is up 14.6% over the past year and 6.6% year to date, even though it has slipped 4.5% over the last month and was roughly flat over the past week with a 0.2% return. Recent news coverage has focused on ONE Gas as a regulated utility that investors often look to for income and stability. This helps frame how the stock trades compared to faster growing...
NasdaqGM:VERI
NasdaqGM:VERISoftware

Veritone’s New Job Acceleration Tool and Equity Raise Could Be A Game Changer For Veritone (VERI)

In May 2026, Veritone, Inc. launched its Job Acceleration feature within the Broadbean programmatic recruitment platform and later filed a US$50.00 million at-the-market follow-on common stock offering, while reporting first-quarter 2026 sales of US$20.26 million and a net loss of US$19.51 million and reaffirming full-year revenue and net loss guidance. The Job Acceleration tool gives recruiters a pay-for-performance, self-serve way to boost visibility for urgent roles without disrupting...
NYSE:ASB
NYSE:ASBBanks

Associated Banc-Corp Expands Minneapolis Wealth Unit As Valuation Screens Undervalued

Associated Banc-Corp (NYSE:ASB) is expanding its private wealth business in Minnesota with new senior hires in Minneapolis. The additions are focused on serving high-net-worth clients and supporting integration of acquired clients in the Twin Cities market. This move reflects fresh attention on Minneapolis after earlier expansion efforts that centered on Dallas commercial banking. Associated Banc-Corp, trading at $28.01, has delivered a 26.4% return over the past year and is up 103.8% over...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Ichor Holdings (ICHR) Taps New ATM Equity Program Is Its Capital Strategy Quietly Shifting Gears

Ichor Holdings, Ltd. recently filed an omnibus shelf registration covering ordinary shares, preferred stock and warrants, and announced a US$200,000,000 at-the-market follow-on equity offering of its ordinary shares. This combination of flexible capital-raising tools and a sizable equity program introduces potential dilution considerations that could affect how investors assess Ichor’s longer-term funding plans and business trajectory. We’ll now examine how this newly announced...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

Is LeMaitre Vascular (LMAT) Pricing Reflecting Too Much Optimism After Its Recent Share Rise?

Beyond the headline share price, if you are asking whether LeMaitre Vascular stock offers good value today, the answer depends on how you look at valuation and which metrics you trust most. Recently, the stock closed at US$97.75, with the price up 0.5% over the past week, down 13.3% over the past month, and up 21.9% year to date and 21.2% over the past year, so recent moves may have shifted how investors view both upside and risk. This article is part of ongoing coverage of LeMaitre Vascular,...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Hamilton (BAH) EPS Decline And Margin Drift Test Bullish Valuation Narrative

Booz Allen Hamilton Holding FY 2026 Earnings Snapshot Booz Allen Hamilton Holding (BAH) closed FY 2026 with fourth quarter revenue of US$2.8b and basic EPS of US$1.73, with trailing twelve month revenue at US$11.2b and EPS at US$6.92, setting the stage for investors to reassess the stock at a share price of US$78.68. Over recent periods, the company has seen quarterly revenue move between US$2.6b and US$2.9b while basic EPS has ranged from US$1.42 to US$2.17, giving you a clear view of how...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Is Warner Bros. Discovery (WBD) Pricing Reflecting DCF And P/S Signals After Netflix Bid Collapse

Wondering if Warner Bros. Discovery stock at US$27.03 is offering good value or just chasing headlines? This article focuses squarely on what the current price might mean for you as a shareholder or potential investor. The stock has been relatively steady over the past week, up 0.2%, and is down 1.1% over the past month and 5.2% year to date. It has returned 200.3% over the past year and 136.3% over three years, while being down 15.8% over five years. Recent attention around Warner Bros...